Clinical Trial Update: Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids [Phase 1]

View source ↗

Summary

Phase 1 trial investigating omega-3 fatty acids to reduce dyskinesia in Parkinson's disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED | Results posted: 2018-05-29